4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-26-000229
CEO and CFO bought 4,300 shares at $21.36 ($91,848)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2025-12-31 | Purchase | +4,300 | $21.36 | $91,848 | 5,599,402 | D: show line 1 in the form |
| Open-market purchases · 4,300 sh · avg $21.36 · $91,848 | |||||||
Loading xslF345X05/ownership.xml…